文献速递儿童心血管与肾脏儿童内分泌与遗传代谢

特纳综合征患者心脏手术后的三十年生存分析

Thirty-Year Survival after Cardiac Surgery for Patients with Turner Syndrome.
PubMed 文献 · J Pediatr · 2021-08-24

该研究基于美国先天性心脏病手术登记系统,评估特纳综合征患者先心术后长期生存,重点分析左心梗阻性病变(LHOL)。结果显示,双心室LHOL术后出院者30年无移植生存率与无综合征对照相似(90.4% vs 90.9%),但特纳综合征患者心血管疾病事件风险显著升高。

要点

  • 双心室LHOL术后出院者30年无移植生存率特纳综合征为90.4%,无综合征对照为90.9%。
  • 特纳综合征患者心血管疾病事件风险较男性对照高(aHR 3.72),较女性对照高(aHR 4.55)。
  • 左心发育不良变异型术后出院生存率特纳综合征为33%,无综合征为51%,样本量小难以比较。

核心结论

  • 特纳综合征合并双心室LHOL术后出院者30年无移植生存率与无综合征对照相似,但心血管疾病事件风险仍升高。

研究设计与样本

  • 基于美国儿科心脏护理联盟登记系统,纳入1982至2011年间<21岁接受先心手术的特纳综合征患者,随访至2019年。
  • 共识别179例特纳综合征LHOL手术患者:161例双心室病变(主动脉缩窄149例,主动脉瓣狭窄12例),18例左心发育不良变异型。

主要发现

  • 双心室LHOL术后出院者中,特纳综合征30年无移植生存率90.4%,无综合征对照90.9%(aHR 1.15,95%CI 0.64-2.04)。
  • 左心发育不良变异型术后出院生存率特纳综合征33%,无综合征51%,样本量小难以进行有意义的比较。
  • 特纳综合征患者心血管疾病事件风险较男性对照升高(aHR 3.72,95%CI 1.64-8.39),较女性对照升高(aHR 4.55,95%CI 1.87-11.06),排除心力衰竭死亡。

临床怎么用

  • 对特纳综合征先心术后患者应终身监测心血管疾病风险,即使双心室LHOL术后生存率与无综合征者相似。

局限性

  • 左心发育不良变异型样本量小,无法进行有意义的生存比较。
  • 研究为回顾性登记数据分析,可能存在未调整的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate long-term survival in patients with Turner syndrome after congenital heart surgery with a focus on left heart obstructive lesions (LHOLs). STUDY DESIGN: We queried the Pediatric Cardiac Care Consortium, a US-based registry of congenital heart surgery, for patients with Turner syndrome undergoing congenital heart surgery at <21 years of age between 1982 and 2011. Outcomes were obtained from the Pediatric Cardiac Care Consortium and from national death and transplant registries through 2019. Survival of patients with Turner syndrome and nonsyndromic patients with similar LHOL was compared by Kaplan-Meier survival curves and Cox regression adjusted for age, congenital heart disease, and era. RESULTS: We identified 179 patients with Turner syndrome operated for LHOL: 161 with 2-ventricle lesions (coarctation n = 149, aortic stenosis n = 12) and 18 with hypoplastic left heart (HLH) variants. There were 157 with 2-ventricle LHOL and 6 with HLH survived to discharge. Among survivors to hospital discharge, the 30-year transplant-free survival was 90.4% for Turner syndrome with 2-ventricle lesions and 90.9% for nonsyndromic comparators (adjusted hazard ratio [aHR] 1.15, 95% CI 0.64-2.04). The postdischarge survival for HLH was 33% for Turner syndrome and 51% for nonsyndromic patients, with these numbers being too small for meaningful comparisons. There was a higher risk for cardiovascular disease events in patients with Turner syndrome vs male (aHR 3.72, 95% CI 1.64-8.39) and female comparators (aHR 4.55, 95% CI 1.87-11.06) excluding heart failure deaths. CONCLUSIONS: The 30-year transplant-free survival is similar for patients with Turner syndrome and nonsyndromic comparators with operated 2-ventricle LHOL without excess congenital heart disease risk. However, patients with Turner Syndrome still face increased cardiovascular disease morbidity, stressing the importance of lifelong comorbidity surveillance in this population.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Alam S, Claxton JS, Mortillo M, et al. Thirty-Year Survival after Cardiac Surgery for Patients with Turner Syndrome. J Pediatr. 2021. PMID: 34450123. doi:10.1016/j.jpeds.2021.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。